Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Ludlam

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Artery|January 1, 1980
The assessment of platelet function in vivo by measurement of beta-thromboglobulin, platelet factor 4 and platelet survivalC A Ludlam
Lancet (London, England)|May 1, 1993
Haemophilia B and factor IX mutationsD Stirling, C A Ludlam
Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic concentrates for the treatment of congenital deficiencies of factors VII, XI, and XIIID Stirling, C A Ludlam
Thrombosis and Haemostasis|April 7, 1987
Acquired factor VIII inhibitor associated with multiple sclerosis, successfully treated with porcine factor VIIIC Hoyle, C A Ludlam
British Journal of Haematology|June 1, 1976
Studies on liberation of beta-thromboglobulin from human platelets in vitroC A Ludlam, J D Cash
British Journal of Haematology|August 25, 1999
Is albumin harmful?G B Drummond, C A Ludlam
Journal of Thrombosis and Haemostasis : JTH|July 26, 2006
Proposal to establish a European Association for Hemophilia and Allied DisordersC A Ludlam, P M Mannucci,
Lancet (London, England)|April 17, 1993
von Willebrand's variantsC A Ludlam, C M Steel
Blood Reviews|March 1, 1992
Immunological abnormalities in haemophiliacsH G Watson, C A Ludlam
British Journal of Haematology|February 1, 1995
Acquired haemophilia and its managementA E Morrison, C A Ludlam
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Artery|January 1, 1980
The assessment of platelet function in vivo by measurement of beta-thromboglobulin, platelet factor 4 and platelet survivalC A Ludlam
Lancet (London, England)|May 1, 1993
Haemophilia B and factor IX mutationsD Stirling, C A Ludlam
Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic concentrates for the treatment of congenital deficiencies of factors VII, XI, and XIIID Stirling, C A Ludlam
Thrombosis and Haemostasis|April 7, 1987
Acquired factor VIII inhibitor associated with multiple sclerosis, successfully treated with porcine factor VIIIC Hoyle, C A Ludlam
British Journal of Haematology|June 1, 1976
Studies on liberation of beta-thromboglobulin from human platelets in vitroC A Ludlam, J D Cash
British Journal of Haematology|August 25, 1999
Is albumin harmful?G B Drummond, C A Ludlam
Journal of Thrombosis and Haemostasis : JTH|July 26, 2006
Proposal to establish a European Association for Hemophilia and Allied DisordersC A Ludlam, P M Mannucci,
Lancet (London, England)|April 17, 1993
von Willebrand's variantsC A Ludlam, C M Steel
Blood Reviews|March 1, 1992
Immunological abnormalities in haemophiliacsH G Watson, C A Ludlam
British Journal of Haematology|February 1, 1995
Acquired haemophilia and its managementA E Morrison, C A Ludlam
Pageof 18